c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells. [electronic resource]
Producer: 20200504Description: 10336-10344 p. digitalISSN:- 1097-4652
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Celecoxib -- pharmacology
- Cell Line, Tumor
- Colorectal Neoplasms -- drug therapy
- Cyclooxygenase 2 -- metabolism
- Cyclooxygenase 2 Inhibitors -- pharmacology
- Humans
- Neoplastic Stem Cells -- drug effects
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.